Free Shipping on purchases over €100

Zenement Berbelipid Complex, 120 vegan capsules

BerbeLipid Complex combines Berberine from Berberis aristata and Monacolin K from Red Yeast Rice with CoQ10, Policosanol and Astaxanthin, along with Vitamin B1 and Active Folate, in a vegan formula intended for daily use.

SKU: ZE8436589810211
-15%
22.10
€25.97

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

BerbeLipid Complex is a food supplement formulated with Berberine from Berberis aristata and Monacolin K from Red Yeast Rice, combined with CoQ10, Policosanol and Astaxanthin, along with Vitamin B1 and Active Folate. A focused composition of key ingredients, in defined doses, designed for daily use. The Berberine used comes from the root of Berberis aristata, a species native to the northern Himalayas traditionally used and valued for its more complete profile compared to other species of the Berberis genus. This selection makes it possible to place Berberine of natural origin at the heart of the formula, integrated into a balanced combination of plant-based active ingredients. In addition, the formula incorporates Vitamin B1 (Thiamine), which contributes to normal energy metabolism and normal heart function, providing a clear functional value within the composition. To complete the formulation, BerbeLipid Complex includes Active Folate in the form of Calcium L-Methylfolate, a form directly usable by the body. All this is contained in vegetarian capsules, with a simple dosage of one capsule per day. The product is 100% vegan, GMO-free, gluten-free, soya-free, lactose-free and magnesium stearate-free. It comes in a pack of 120 capsules, equivalent to a 4-month supply, and is made in Spain.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.